ArticleJCO precision oncology2022

Sustained Response to the Mitogen-Activated Extracellular Kinase Inhibitor Trametinib in a Spindle Cell Sarcoma Harboring a QKI-RAF1 Gene Fusion.

François Panet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.